amplified and DNA from each of these populations as well as from unsorted cells was deep-80 sequenced to identify the targeted genes in each population ( Fig. 1c and Fig. S2 ). The fold enrichment 81 and depletion of gRNAs in the hypo-responsive population versus the hyper-responsive population
82
was calculated for each screen (Fig. S3 , Table S1 and Table S2 ). We also integrated multiple gRNAs 83 per gene using Mageck (see Methods) comparing the hyporesponsive and hyperresponsive 84 populations calculated as robust rank aggregations scores and depicted in Fig. 1d and e. Similar 85 results were obtained when each sorted population was compared to unsorted cells (Table S2 ). The 86 two screens yielded many common hits, but there were some differences, such as numerous hits in the 87 2'3'-cGAMP screen including STAT2, IRF9, IFNAR1, and IFNAR2 (Table S2 ). Hence, the 2'3'-RR
88
CDA screen may have been mostly dependent on intrinsic STING signaling, whereas the 2'3'-89 cGAMP screen may have been partly dependent on autocrine/paracrine IFN-b signaling.
90
In both CDN screens, the top hits in the hypo-responsive population (i.e. the genes most 91 important for robust responses to CDNs) included the transcription factor IRF3, which acts directly 92 downstream of STING. One of the five gRNAs for STING itself was also enriched in hyporesponsive 93 cells from both screens, though the other STING gRNAs were not, presumably because they were 94 ineffective at interfering with STING expression (Table S1 ). Other significant hits included genes 95 involved in transcription, splicing, and immune modulation (Table S2 ).
96
One of the most significant hits in both screens was the SLC19A1 gene. SLC19A1 is a cell 97 surface transporter known as the reduced folate carrier. SLC19A1 and another transporter, SLC46A1,
98
are responsible for uptake of folate from the extracellular environment 29 . To validate the role of
99
SLC19A1 in CDN stimulation, the top two enriched SLC19A1-targeting gRNAs from the 2'3'-RR
100
CDA screen were used to stably deplete SLC19A1 in THP-1 cells expressing dCas9-KRAB ( 
118
Taken together, our data show reduced responses to CDNs in SLC19A1-deficient cells and much
119
amplified responses in cells overexpressing SLC19A1, as might be expected for a CDN transporter.
120
Together, these data support a central role of the SLC19A1 transporter in responses to several cyclic 121 dinucleotides, including the mammalian CDN 2'3'-cGAMP.
122
Based on our findings, we tested whether the drug sulfasalazine (SSZ), a non-competitive 
126
whereas responses to hIFN-β stimulation were only modestly inhibited (Fig. 2g) . The concentrations 127 required for inhibition were only modestly higher than those that inhibit uptake of folate derivatives in 128 another study 30 . Surprisingly, at lower concentrations, SSZ modestly enhanced stimulation by 2'3'-
129
RR CDA, but had no effect on stimulation by 2'3' cGAMP ( Fig. 2g ).
130
The effect of SLC19A1 on reporter induction by CDNs led us to test the impact of SLC19A1
131
deficiency on endogenous transcriptional targets downstream of STING, including the genes encoding 132 the chemokines CCL5 and CXCL10, which are direct targets of IRF3 31, 32 . In control cells, CCL5 and
133
CXCL10 gene expression was highly elevated 5h after 2'3'-RR CDA stimulation. In cells depleted of IRF3, SLC19A1 or STING, chemokine expression was strongly inhibited, indicating that SLC19A1
135
action is necessary for CDN-induced effects, including those downstream of STING ( Fig. 3a and b) .
136
To directly assess the effect of SLC19A1 on STING pathway activation (Fig. S5) 
154
S6a and b). We next monitored 2'3'-cGAMP uptake by cells expressing different levels of SLC19A1.
155
SLC19A1 overexpression greatly enhanced uptake of [ 32 P] 2'3'-cGAMP by THP-1 cells (Fig. 4a) 
175
Consistent with a direct interaction between 2'3'-cGAMP and SLC19A1, His-tagged SLC19A1 was 176 precipitated by 2'3'-cGAMP immobilized on Sepharose beads ( Fig. 4g and S8 ). This interaction was 177 specific, as free, unbound 2'3'-cGAMP competitively disrupted the 2'3'-cGAMP-SLC19A1 178 interaction ( Fig. 4h and S8 ). As a positive control, His-tagged STING C-terminal domain was also 179 precipitated by 2'3'-cGAMP-Sepharose (Fig 4g and S8 
193
SLC19A1 together was no more effective than depleting SLC19A1 alone (Fig. S11) . These data
194
suggest that yet another transporter that is inhibited by folic acid and sulfasalazine may play a partial
195
role in CDN transport. SLC46A3, another transporter, was also a hit in our screen. Overexpression of
196
SLC46A3 increased the response to CDNs (Fig. S10 ). Depletion of SLC46A3 had a modest effect on
197
reporter induction by both CDNs (Fig. S11) . However, depleting both SLC19A1 and SLC46A3
198
together did not reduce responses more than depletion of SLC19A1 alone (Fig. S11) 
228
Hutchinson Cancer Center, Seattle WA). 293T+hSTING cells were generated at Aduro Biotech Inc.
230
Antibodies and reagents
231
The following antibodies were derived from Cell signaling technologies: rabbit-anti-human TBK1 
256
sequence controlled by the human EF1A promoter, and was generated as described previously 40 .
257
For rescue and overexpression of SLC19A1, SLC46A1, or SLC46A3, a gBLOCK gene fragment 
263
For screen validation using individual gRNAs, gRNAs (table S3) 
271
Conventional CRISPR gRNAs (see 
415
(Perkin-Elmer) was incubated with 1 µM of recombinant DisA in binding buffer at 37°C overnight.
416
The reaction mixture was boiled for 5 min at 95°C and DisA was removed by centrifugation.
417
Recombinant His-tagged RECON was then used to further purify the c di-AMP reaction mixture. 100 
423
Nucleotide-Binding Assays
424
The ability of radiolabeled 2'3' cGAMP and c di-AMP to bind recombinant STING was evaluated by
425
DRaCALA (differential radial capillary action of ligand assay) analysis, as previously described 48 .
426
Briefly, varying concentrations of recombinant STING were incubated with ~1 nM of radiolabeled 
498
The soluble fraction was then analyzed by SDS-PAGE followed by Coomasie staining.
500
Cell lysis and immunoblotting
501
For anti-SLC19A1 immunoblotting, cells were lysed and proteins were separated by SDS-PAGE as 
701
Target gene gRNA name sequence (5'-3') CRISPR system Cells were gated based on their forward scatter (FSC) and side scatter (SSC) using gate P1. P1-population was selected based on the expression of blue fluorescent protein (BFP, fluorescent marker for the CRISPRi gRNAs) and GFP (marker for the expression of the reporter construct) using gate P2. In gate P3, the doublet cells present in gate P2 were excluded. In gate P4 and P5, population P3 was gated based on tdTomato expression. The lowest 25% of cells expressing tdTomato were selected in gate P4, and the highest 25% of cells expressing tdTomato were selected in gate P5. were stimulated with 2'3'-RR CDA (1.25 µg/ml), 2'3'-cGAMP (15 µg/ml) or hIFNb (100 ng/ml). tdTomato reporter expression was measured by flow cytometry 18-22h after stimulation. Combined data of three independent experiments. Statistical analysis was performed using an unpaired two-tailed Student's t test. Error bars represent ± SE of independent replicates. *P ≤ 0.05; **P ≤ 0.01;***P ≤0.001; ****P ≤ 0.0001; n.s. not significant. . Cells were stimulated with 2'3'-RR CDA (1.67 µg/ml), 2'3'-cGAMP (10 µg/ml), or hIFN-b (100 ng/ml). tdTomato reporter expression was measured by flow cytometry 18-22h after stimulation. Combined data of three independent experiments. Statistical analysis was performed using a oneway ANOVA followed by a Tukey's post-test, comparing only the effects of depleting SLC46A1 (a) or SLC46A3 (b).
Error bars represent ± SE of independent replicates. *P ≤ 0.05; **P ≤ 0.01; n.s. not significant.
